Celldex to Present at the 2022 Jefferies Global Healthcare Conference

HAMPTON, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that senior management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference in New York City on Wednesday, June 8, 2022 at 8:30 a.m. ET.

A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 30 days following the event.

About Celldex Therapeutics, Inc.Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company ContactSarah CavanaughSenior Vice President, Corporate Affairs & Administration(508) 864-8337[email protected]

Patrick TillSenior Director, Investor Relations & Corporate Communications(484) 788-8560[email protected]

Source: Celldex Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blockchain + AI , Former OpenAI Member Ishant Singh was Appointed as BitYuan Blockchain CEO
• InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Participation at the Robotics Showcase & Demo Day
• Why Former CPAs are Leaving and What Existing CPAs Want: CPA Talent Retention Survey from the PICPA Sheds Light On Accounting’s Retention Challenges